Prices vary per dose
| Wegovy Pill dose | Price |
|---|---|
| 1.5mg | £59.99 was £100.00 |
| 4mg | £119.00 |
| 9mg | £159.00 |
| 25mg | £199.00 |
At checkout, choose to get your treatment dispensed automatically, or to pay as you go.

“Wegovy Pill offers the benefits of semaglutide in a convenient daily tablet.”
Medical Director
Price from £139.99 was £179.99 | Price from £69.99 was £99.99 | Price from £59.99 was £100.00 | Price from £59.99 was £100.00 |
Avg. weight loss 22.5% in 72 weeks1 at the highest dose | Avg. weight loss 20.7% in 72 weeks2 at the highest dose | Avg. weight loss 16.6% in 64 weeks3 at the highest dose | Avg. weight loss 12.4% in 72 weeks4 at the highest dose |
Format Injection | Format Injection | Format Oral tablet | Format Oral tablet |
Wegovy tablets and injections both contain semaglutide and work in the same way. The main differences are:
Some people prefer a daily tablet. Others prefer a weekly injection. Your clinician can help you decide what works best for you.
You’ll start on the lowest dose of 1.5mg, taken once a day. From there, your dose can increase every 30 days. The schedule is:
Your clinician will review your progress at each step and confirm the right dose for you. This gradual increase helps your body adjust and reduces the chance of side effects. Some people stay on a lower dose for longer, and that’s completely fine.
The full treatment effect is usually seen at the maintenance dose of 25mg. We also keep lifestyle front of mind. Finding your rhythm with food, movement and rest is just as important as finding the right dose.
The goal is simple: a balance that helps you feel well, manage side effects and make steady, sustainable progress.
We’re here to support you throughout your weight loss journey, offering tips to help you manage side effects and providing reassurance if you have any concerns.
Side effects tend to be more noticeable when you first start and when your dose increases. They usually improve as your body adjusts.
Very common side effects of oral Wegovy (semaglutide) include stomach upsets like nausea, vomiting, diarrhoea and constipation. You might also experience stomach pain, headaches and fatigue. Headaches and mild stomach problems, which are common, can usually be managed with over-the-counter remedies. To ease nausea, you can try stepping outside for fresh air, sipping cold drinks and eating smaller meals more often.
Less common side effects, affecting fewer than 1 in 100 people, may include a faster heart rate, low blood sugar (also known as hypoglycaemia), kidney stones and pancreatitis.
Rare side effects, occurring in fewer than 1 in 1,000 people, may involve a serious allergic reaction (also known as anaphylaxis) and angioedema, which is a type of swelling beneath the skin that can affect the face, lips, tongue or throat.
For rare, severe or worsening symptoms, we recommend you seek professional medical advice.
Keep an eye on how you feel and report any side effects that do not go away or get worse. Seek immediate medical attention if you experience difficulty breathing, swelling or severe stomach pain.
If you have any questions about side effects or how to manage them, to support you.
Wegovy Pill can interact with other medicines. Always tell your prescriber about everything you’re taking, including prescription medicines, over-the-counter medicines, and supplements.
Full details of medicine interactions are listed in the Patient Information Leaflet (PIL), which you should read before starting treatment.
Always read the patient information leaflet before commencing treatment.
In a 64-week clinical trial, people taking oral Wegovy 25mg lost an average of 16.6% of their body weight.
This means that someone who weighs 100kg could lose around 16.6kg on average in 64 weeks (just over 1 year). This is an example only. It is not a prediction of individual results.3
Around 3 in 10 people in the trial lost 20% or more of their body weight.
Weight loss is gradual and varies between individuals. Some people notice appetite changes within the first few weeks, with more noticeable weight loss typically occurring over time as your dose increases.
If you’ve been taking oral Wegovy consistently for several months and feel you are not seeing the results you were hoping for, reach out to us. Our clinicians can review whether the treatment is right for you or whether an injectable GLP-1 treatment might better support your goals.
No. On average, injectable treatments have shown higher weight loss results in clinical trials.
In separate studies of adults with obesity or overweight, Wegovy Pill resulted in an average weight loss of 16.6% over 64 weeks3, compared to 20.7% with injectable Wegovy at the highest 7.2mg dose over 72 weeks2. Mounjaro (tirzepatide 15mg) has shown an average weight loss of 22.5% in 72 weeks1.
These figures come from different trials in different populations, so they’re not a direct comparison, but they do suggest that injectable treatments can produce greater weight loss, on average.
However, the best treatment is the one you can stick to consistently and long term. For people who find injections a barrier to starting or continuing treatment, Wegovy Pill can be a highly effective option, and some patients on oral Wegovy do achieve weight loss comparable to injectable treatments.
Wegovy tablets are taken once a day, every morning. To make sure the medication is absorbed properly, here’s how to take it:
The tablets can be stored at room temperature. There’s no need for refrigeration.
Potentially, yes. But, it’s worth understanding what switching would mean for you before making a decision.
The Wegovy pen and Wegovy Pill have shown different average weight loss results in clinical trials. In separate studies, adults with obesity or overweight lost 20.7% of their starting body weight after 72 weeks of injectable Wegovy2 (semaglutide 7.2mg) treatment, and 16.6% after 64 weeks of Wegovy Pill 3 (semaglutide 25mg). These figures come from different trials in different populations and aren’t a direct comparison, but they do suggest that switching from the Wegovy pen to Wegovy Pill may mean slower progress or less total weight loss for some people. If the Wegovy pen is working well for you, it’s worth keeping this in mind before deciding to switch.
However, there may be other reasons to consider Wegovy Pill. For example, if you find injections difficult, travel often, or have experienced injection site reactions. The differences between the two treatments are:
Wegovy Pill does not reduce the effectiveness of the oral contraceptive pill. Clinical studies found commonly used oral contraceptives containing ethinylestradiol and levonorgestrel were still effective when taken with semaglutide.
Wegovy Pill should not be used during pregnancy, so women who could become pregnant should use effective contraception while taking Wegovy Pill.
If you experience vomiting or severe diarrhoea, this may affect how well your oral contraceptive pill is absorbed. Follow the advice provided with your contraceptive pill and speak to your GP, pharmacist or call 111 if you are unsure what to do.

Dr. Adam Abbs is Medical Director at MedExpress. He has extensive experience in asynchronous and video consultations, technology-enabled remote examinations and home biomarker testing, with a particular interest in educating both patients and doctors. Adam is a published author and is licensed to practice medicine in the UK and across the EU. He’s also registered in Canada.

Dr. Carla Rodrigues is Head of Medical Operations at MedExpress, having previously held leadership roles in primary care networks and across well-known healthcare organisations. She’s led scientific society groups in the field of sexual medicine, and has also completed training with MIT, Harvard and INSEAD. Here, Carla leads medical operations in the UK, overseeing the delivery of safe care pathways and upholding high standards in prescribing and clinical governance.

Dr. Kavir Matharu is GP Lead at MedExpress, with 10 years’ experience across a range of healthcare settings. She is a practising GP with a background in complex healthcare consulting, having worked on high-level strategic and operational challenges within the health system. She was also selected for a leadership fellowship with the National Medical Director at NHS England. Kavir has a strong interest in healthcare leadership and system improvement, with a focus on high-quality, sustainable care.

Dr. Daryl Perera is GP Lead at MedExpress, with experience across NHS primary care, urgent care and private practice. He has extensive experience in digital healthcare and clinical leadership, and oversees clinical governance and patient safety across our digital health services. His work spans urgent care and preventative medicine, with particular interests in men’s health, obesity management, and sport and exercise medicine. Daryl has worked across a range of NHS and private healthcare organisations and previously held a GP Director role.

Head of Medical Affairs
BSc (Hons), MSc, PhD
Dr. Sophie Dix is Head of Medical Affairs at MedExpress, and a behavioural neuroscientist with over 25 years’ experience across the pharmaceutical industry, charity sector and health technology. Her work has focused on understanding how to manage and treat conditions affecting both mind and body, bringing together scientific insight with real-world care. Sophie is passionate about evidence and ensuring people have access to the right treatment at the right time.

Medical Writer
BSc (Hons), MSc, PhD
Dr. Zoe Lees is a Medical Writer at MedExpress, specialising in clear, evidence-based health communications. She completed her postgraduate research at the University of Glasgow, focusing on metabolic complications of pregnancy and the role of adipose tissue function. Zoe brings a strong scientific foundation to her work and is committed to delivering content that is both accurate and accessible, grounded in robust research.

Liyya Patel is Deputy Chief Pharmacist at MedExpress UK, with over 13 years’ experience supporting the organisation’s growth and development. She is responsible for ensuring pharmacy services are safe, compliant and meet all regulatory standards, playing a key role in maintaining high-quality clinical care.

Dr. Olivia de Rougemont is GP Lead at MedExpress, with over 14 years’ experience across the NHS and private sectors. She has extensive experience in digital and in-person care, with a particular interest in women’s health, preventative medicine, and delivering patient-centred support that feels clear and accessible. Olivia also leads and mentors GPs, and brings a global perspective shaped by her experience working across different healthcare systems.

Dr. Karuna is GP Lead at MedExpress. She brings a broad portfolio of experience in NHS primary care, including general practice, NHS 111, and urgent care services. She has extensive expertise in digital healthcare, providing remote consultations to both NHS and private patients, and previously held a senior leadership role in a large scale digital-first healthcare platform.
Found it cheaper? We’ll match it.*
As you progress, we’ll support you in changing your dose or treatment.
Over 500 UK-registered clinicians for support whenever you need it.
Get your orders dispensed automatically, or choose to pay-as-you-go.
*Price match applies to providers listed in the terms and conditions
SURMOUNT-1, 72-week study of adults with obesity using Mounjaro (tirzepatide 15mg). Individual results vary.
STEP UP, 72-week study of adults with obesity using Wegovy (semaglutide 7.2mg). Individual results vary.
OASIS 4, 64-week study of adults with obesity using oral semaglutide 25mg alongside lifestyle changes. Individual results vary.
ATTAIN-1, 72-week study of adults with obesity using the maximum dose of orforglipron alongside lifestyle changes. Individual results vary.
Discreet packaging
UK-registered pharmacy
No waiting rooms
Fast delivery
24/7 support
Price match
Trusted by 2.3m+ people
57k reviews
No lock-in contracts